Evaluation of the International Prognostic Index for Chronic Lymphocytic Leukemia (CLL-IPI) and Validation of a Proposed Novel Risk Model (BALL Score) in Real-World Relapsed/Refractory (R/R) CLL Patients Receiving Idelalisib and Rituximab
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-126717
Abstract: The CLL-IPI score, which combines genetic, biochemical, and clinical parameters, represents a simple worldwide model able to refine risk stratification for CLL patients. This score, developed in the era of chemo-immunotherapy, has not been gauged… read more here.
Keywords: cll; risk; cll ipi; ball score ... See more keywords
CLL-IPI applied in Binet A CLL: a nationwide cohort study
Sign Up to like & getrecommendations! Published in 2022 at "Blood Advances"
DOI: 10.1182/bloodadvances.2021006259
Abstract: The Chronic Lymphocytic Leukemia International Prognostic Index (CLL-IPI) is thoroughly validated and commonly applied in clinical practice and research in chronic lymphocytic leukemia (CLL). 1-3 In a recent single-center study, Parikh et al 4 demonstrated… read more here.
Keywords: cll ipi; ipi applied; applied binet; cohort ... See more keywords
Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data.
Sign Up to like & getrecommendations! Published in 2022 at "Blood advances"
DOI: 10.1182/bloodadvances.2021006351
Abstract: Highly variable clinical course, immune dysfunction and complex genetic blueprint pose challenges for treatment decisions and the management of risk of infection in patients with chronic lymphocytic leukemia (CLL). In recent years, the use of… read more here.
Keywords: cll ipi; ipi variables; para clinical; recurrent gene ... See more keywords